Colorectal cancer stem cell: a potential therapeutic target

被引:7
|
作者
Tao, Haiying [1 ]
Zhu, Yongliang [1 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 2, Dept Gastroenterol, Sch Med, Hangzhou 310009, Zhejiang, Peoples R China
来源
CLINICAL & TRANSLATIONAL ONCOLOGY | 2011年 / 13卷 / 12期
关键词
Colorectal cancer; Stem cell; Marker; Pathway; Targeted intervention; SMALL-INTESTINE; COLON; EXPRESSION; MARKER; DIFFERENTIATION; ANTAGONISTS; HIERARCHY; RENEWAL; GROWTH;
D O I
10.1007/s12094-011-0743-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The discovery of cancer stem cells has improved our understanding of tumour occurrence and development. Colorectal cancer stem cells may be derived from mutations in normal intestinal epithelial stem cells. CD133(+) and aldehyde dehydrogenase 1 (ALDH1)(+) cells have strong tumorigenic capacities and may represent different subpopulations of colorectal cancer stem cells. Multiple signalling pathways, especially the Wnt pathway, are important in colorectal cancer occurrence and development, and maintaining the stemness of colorectal cancer stem cells. Identifying colorectal cancer stem cells and understanding the related signalling pathways are important for developing new targeted interventions for colorectal cancer.
引用
收藏
页码:833 / 838
页数:6
相关论文
共 50 条
  • [31] Cancer stem cell metabolism: a potential target for cancer therapy
    Deshmukh, Abhijeet
    Deshpande, Kedar
    Arfuso, Frank
    Newsholme, Philip
    Dharmarajan, Arun
    [J]. MOLECULAR CANCER, 2016, 15
  • [32] Endothelial nitric oxide synthase in colorectal cancer: A potential new therapeutic target in stem cell-like poor-prognosis subtype
    Penarando, J.
    Mena, R.
    Guil, S.
    Lopez-Sanchez, L. M.
    Villar, C.
    Sanchez, R.
    Centeno, M.
    Jimenez Arranz, A.
    Gomez Barbadillo, J.
    Diaz, C.
    De la Haba-Rodriguez, J.
    Aranda, E.
    Myant, K.
    Rodriguez Ariza, A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 69 : S46 - S46
  • [33] Cancer stem cells with increased metastatic potential as a therapeutic target for esophageal cancer
    Wang, D.
    Plukker, J. Th. M.
    Coppes, R. P.
    [J]. SEMINARS IN CANCER BIOLOGY, 2017, 44 : 60 - 66
  • [34] Cancer stem cell characteristics and their potential as therapeutic targets
    Jacqueline R. Lim
    Josette Mouawad
    Olivia K. Gorton
    William A. Bubb
    Ann H. Kwan
    [J]. Medical Oncology, 2021, 38
  • [35] Cancer Stem Cell Metabolism and Potential Therapeutic Targets
    Snyder, Vusala
    Reed-Newman, Tamika C.
    Arnold, Levi
    Thomas, Sufi Mary
    Anant, Shrikant
    [J]. FRONTIERS IN ONCOLOGY, 2018, 8
  • [36] Cancer stem cell characteristics and their potential as therapeutic targets
    Lim, Jacqueline R.
    Mouawad, Josette
    Gorton, Olivia K.
    Bubb, William A.
    Kwan, Ann H.
    [J]. MEDICAL ONCOLOGY, 2021, 38 (07)
  • [37] NFATC2 is a novel therapeutic target for colorectal cancer stem cells
    Lang, Tingyuan
    Ding, Xiaojuan
    Kong, Liangsheng
    Zhou, Xiaoyan
    Zhang, Zhiqi
    Ju, Huangxian
    Ding, Shijia
    [J]. ONCOTARGETS AND THERAPY, 2018, 11 : 6911 - 6924
  • [38] Cell cycle regulation in cancer stem cell as a promising therapeutic target to eradicate cancer
    Nakayama, Keiichi I.
    [J]. CANCER SCIENCE, 2021, 112 : 130 - 130
  • [39] Adrenomedullin is a therapeutic target in colorectal cancer
    Wang, Liangjing
    Gala, Manish
    Yamamoto, Masayoshi
    Pino, Maria S.
    Kikuchi, Hirotoshi
    Shue, Daniel S.
    Shirasawa, Senji
    Austin, Thomas R.
    Lynch, Maureen P.
    Rueda, Bo R.
    Zukerberg, Lawrence R.
    Chung, Daniel C.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (09) : 2041 - 2050
  • [40] SPOCD1 as a potential prognostic biomarker and therapeutic target for colorectal cancer
    Kong, Xiangxu
    Wan, Changshan
    Zhong, Weilong
    Chen, Qiuyu
    Ding, Qian
    Liu, Wentian
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 66 - 66